These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation). Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134 [TBL] [Abstract][Full Text] [Related]
3. Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation. Roldán V; Vílchez JA; Manzano-Fernández S; Jover E; Gálvez J; Puche CM; Valdés M; Vicente V; Lip GY; Marín F Stroke; 2014 Mar; 45(3):696-701. PubMed ID: 24519407 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of Serum N-Terminal Pro-Brain Natriuretic Peptide Level over Heart Failure for Stroke Events and Deaths in Patients with Atrial Fibrillation. Kuronuma K; Okumura Y; Morikawa T; Yokoyama K; Matsumoto N; Tachibana E; Oiwa K; Matsumoto M; Kojima T; Haruta H; Nomoto K; Sonoda K; Arima K; Kogawa R; Takahashi F; Kotani T; Ohkubo K; Fukushima S; Itou S; Kondo K; Chiku M; Ohno Y; Onikura M; Hirayama A; Int Heart J; 2020 May; 61(3):492-502. PubMed ID: 32418966 [TBL] [Abstract][Full Text] [Related]
5. Moderate Levels of N-Terminal Pro-B-Type Natriuretic Peptide is Associated with Increased Risks of Total and Ischemic Strokes among Japanese: The Circulatory Risk in Communities Study. Ebihara K; Yamagishi K; Umesawa M; Muraki I; Cui R; Imano H; Kubota Y; Hayama-Terada M; Shimizu Y; Ohira T; Sankai T; Okada T; Kitamura A; Kiyama M; Iso H; J Atheroscler Thromb; 2020 Aug; 27(8):751-760. PubMed ID: 31932552 [TBL] [Abstract][Full Text] [Related]
6. N-terminal pro-B-type natriuretic peptide and stroke risk: the reasons for geographic and racial differences in stroke cohort. Cushman M; Judd SE; Howard VJ; Kissela B; Gutiérrez OM; Jenny NS; Ahmed A; Thacker EL; Zakai NA Stroke; 2014 Jun; 45(6):1646-50. PubMed ID: 24757103 [TBL] [Abstract][Full Text] [Related]
7. Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation. Sharma A; Hijazi Z; Andersson U; Al-Khatib SM; Lopes RD; Alexander JH; Held C; Hylek EM; Leonardi S; Hanna M; Ezekowitz JA; Siegbahn A; Granger CB; Wallentin L Circulation; 2018 Oct; 138(16):1666-1676. PubMed ID: 29871978 [TBL] [Abstract][Full Text] [Related]
8. Comparison of BNP and NT-proBNP in Patients With Heart Failure and Reduced Ejection Fraction. Rørth R; Jhund PS; Yilmaz MB; Kristensen SL; Welsh P; Desai AS; Køber L; Prescott MF; Rouleau JL; Solomon SD; Swedberg K; Zile MR; Packer M; McMurray JJV Circ Heart Fail; 2020 Feb; 13(2):e006541. PubMed ID: 32065760 [TBL] [Abstract][Full Text] [Related]
9. Effects of Atrial Fibrillation Screening According to N-Terminal Pro-B-Type Natriuretic Peptide: A Secondary Analysis of the Randomized LOOP Study. Xing LY; Diederichsen SZ; Højberg S; Krieger DW; Graff C; Frikke-Schmidt R; Olesen MS; Brandes A; Køber L; Haugan KJ; Svendsen JH Circulation; 2023 Jun; 147(24):1788-1797. PubMed ID: 37061802 [TBL] [Abstract][Full Text] [Related]
10. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. Mohr JP; Thompson JL; Lazar RM; Levin B; Sacco RL; Furie KL; Kistler JP; Albers GW; Pettigrew LC; Adams HP; Jackson CM; Pullicino P; N Engl J Med; 2001 Nov; 345(20):1444-51. PubMed ID: 11794192 [TBL] [Abstract][Full Text] [Related]
11. N-Terminal Pro-B-Type Natriuretic Peptide Levels for Risk Prediction in Patients With Heart Failure and Preserved Ejection Fraction According to Atrial Fibrillation Status. Kristensen SL; Mogensen UM; Jhund PS; Rørth R; Anand IS; Carson PE; Desai AS; Pitt B; Pfeffer MA; Solomon SD; Zile MR; Køber L; McMurray JJV Circ Heart Fail; 2019 Mar; 12(3):e005766. PubMed ID: 30871349 [TBL] [Abstract][Full Text] [Related]
12. The role of warfarin and aspirin in secondary prevention of stroke. Elkind MS Curr Cardiol Rep; 2004 Mar; 6(2):135-42. PubMed ID: 14759359 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial Fibrillation. Kristensen SL; Jhund PS; Mogensen UM; Rørth R; Abraham WT; Desai A; Dickstein K; Rouleau JL; Zile MR; Swedberg K; Packer M; Solomon SD; Køber L; McMurray JJV; Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29018174 [TBL] [Abstract][Full Text] [Related]
14. NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and the Risk of Stroke. Di Castelnuovo A; Veronesi G; Costanzo S; Zeller T; Schnabel RB; de Curtis A; Salomaa V; Borchini R; Ferrario M; Giampaoli S; Kee F; Söderberg S; Niiranen T; Kuulasmaa K; de Gaetano G; Donati MB; Blankenberg S; Iacoviello L; Stroke; 2019 Mar; 50(3):610-617. PubMed ID: 30786848 [TBL] [Abstract][Full Text] [Related]